| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |